This guidance will partially update the following:
- Status:
- In progress
- Developed as:
- CG
Provisional Schedule
- Committee meeting: 6:
- 17 October 2025
- Expected publication:
- 26 February 2026
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 11 September 2025 | Declaration of interests |
| 05 September 2025 | Committee list updated |
| 05 September 2025 | Committee meeting: 5 |
| 16 July 2025 | Committee meeting: 4 |
| 06 June 2025 | Committee meeting: 3 |
| 09 May 2025 | Committee meeting: 2 |
| 04 April 2025 | Committee meeting: 1 |
| 17 December 2024 | Committee meeting: Scoping meeting 2 |
| 07 November 2024 - 21 November 2024 | Draft scope consultation |
| 06 November 2024 | Stakeholder list updated |
| 11 October 2024 | Committee meeting: Scoping meeting 1 |
| 03 October 2024 | This update will cover: Ovarian Function Suppression, Chemotherapy for Advanced Breast Cancer and Biological Therapy for Advanced Breast Cancer |
For further information on the guideline development process, please see how we develop NICE guidelines